StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 1M, down 79.5% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M-79.5%
FY2024Dec 31, 20243M+1494.1%
FY2023Dec 31, 20230M–

More Regentis Biomaterials figures

See a number that looks wrong?